# OLPRUVA
> **NDA214860** · New Drug Application · Sponsor: ACER · Approved 2022-12-22
## Drug
- **FDA Application Number:** NDA214860
- **Application type:** New Drug Application
- **Brand name:** OLPRUVA
- **Generic name:** Sodium Phenylbutyrate
- **Active ingredients:** SODIUM PHENYLBUTYRATE
- **Dosage form:** FOR SUSPENSION
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** ACER
- **First approval:** 2022-12-22
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=214860)
---
*MORVS · CC0 1.0*